What are FDA’s Guiding Principles of Good AI Practice in Drug Development?

Here they are: Human-centric by design. The development and use of AI technologies align with ethical and human-centric values.Risk-based approach. The development and use of AI technologies follow a risk-based approach with proportionate validation, risk mitigation, and oversight based on the context of use and determined model risk.Adherence to standards. AI technologies adhere to relevant…

Read More